Journal of Clinical Medicine (Sep 2020)

Atrial Substrate Underlies the Recurrence after Catheter Ablation in Patients with Atrial Fibrillation

  • Yong-Soo Baek,
  • Jong-Il Choi,
  • Yun Gi Kim,
  • Kwang-No Lee,
  • Seung-Young Roh,
  • Jinhee Ahn,
  • Dong-Hyeok Kim,
  • Dae In Lee,
  • Sung Ho Hwang,
  • Jaemin Shim,
  • Jin Seok Kim,
  • Dae-Hyeok Kim,
  • Sang-Weon Park,
  • Young-Hoon Kim

DOI
https://doi.org/10.3390/jcm9103164
Journal volume & issue
Vol. 9, no. 10
p. 3164

Abstract

Read online

Prediction of recurrences after catheter ablation of atrial fibrillation (AF) remains challenging. We sought to investigate the long-term outcomes after AF catheter ablation. A total of 2221 consecutive patients who underwent catheter ablation for symptomatic AF were included in this study (mean age 55 ± 11 years, 20.3% women, and 59.0% paroxysmal AF). Extensive ablation, in addition to circumferential pulmonary vein isolation, was more often accomplished in patients with non-paroxysmal AF than in those with paroxysmal AF (87.4% vs. 25.3%, p p = 0.765). Subanalysis showed that the extent of late gadolinium enhancement (LGE), as assessed by cardiac magnetic resonance, is greater in patients with recurrence than in those without recurrence (36.2 ± 23.9% vs. 21.8 ± 13.7%, p p p = 0.020), left atrium dimension ≥ 45 mm (HR 1.284, 95% CI 1.085–1.518, p = 0.004), AF duration (HR 1.020 per year, 95% CI 1.006–1.034, p = 0.004), and LGE ≥ 25% (HR 1.726, 95% CI 1.330–2.239, p < 0.001) are significantly associated with AF recurrence after catheter ablation. This study showed that repeated catheter ablation improves the clinical outcomes of patients with non-paroxysmal AF, suggesting that AF substrate based on LGE may underpin the mechanism of recurrence after catheter ablation.

Keywords